2018 Oncology Nursing Drug Handbook. Written especially for nurses caring for patients with cancer. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping on the locked topic will launch the in-app purchase screen).
The 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole, daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome injection (Onivyde), ixazomib (Ninlaro), melphalan for injection (Evoela), necitumumab (Portrazza), osimertinib (Targrisso), pentamidine, posaconazole, peramivir, rolapitant (Varubi) , talimogene laherparepvec (Imlygic), Tamiflu, trabectedin (Yondelis), uridine triacetate (Vistogard granules), venetoclax (Venclexta), vincristine liposome injection (Marqibo), and zanamivir.
Table of Content:
I Cancer Treatment
1 Introduction to Chemotherapy Drugs
2 Biologic Response Modifier Therapy
3 Cytoprotective Agents
4 Molecularly Targeted Therapies
5 Chemobiotherapy for Noncancer Diseases
II Symptom Management
7 Nausea and Vomiting
8 Anorexia and Cachexia
9 Anxiety and Depression
10 Managing Tumor-Related Skeletal Events and Hypercalcemia
Appendix 1 : Occupational Exposure to Hazardous Drugs
Appendix 2 :Common Terminology Criteria for Adverse Events (CTCAE)
Gail M. Wilkes, MS, APRN-BC, AOCN-Oncology Nursing Consultant, Kilauea, Hawaii
- iPhone X support
- UI/UX enhancement
- Minor bug fixes
Ratings and ReviewsSee All
Very good but a clarifying question
The content on this app looks to be useful and I recognize the author names from other oncology nursing resources, which increases my trust. However: does the $60 “lifetime access” fee include automatic content updates? Otherwise, it hardly seems worthwhile. Thanks!
Developer Response ,
We are happy to hear you find our resources trustworthy, we receive the content directly from our publishers. When you purchase our resources you receive one year of free content updates, after which time you can use the version you own as long as you want.
Not useful without paying 59.99 for basically any content you click on.
In-App PurchasesSee All
- Skyscape Medpresso Inc
- 51.2 MB
Requires iOS 9.0 or later. Compatible with iPhone, iPad, and iPod touch.
- Age Rating
- Frequent/Intense Medical/Treatment Information
- Infrequent/Mild Alcohol, Tobacco, or Drug Use or References
- © (c) 1998-2019 Skyscape Medpresso, Inc. All rights reserved.
- In-App Purchases
- Oncology Nursing Drug Handbook $59.99
With Family Sharing set up, up to six family members can use this app.